Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes

Acta Diabetologica

Volumn 51, Issue 2, 2014, Pages 225-232

  Du, Yatao ^a   Zhang, Huihui ^a   Montano, Sergio ^a   Hegestam, Jesper ^b   Ekberg, Neda Rajamand ^c   Holmgren, Arne ^a   Brismar, Kerstin ^c   Ungerstedt, Johanna S ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Vårdcentralen Söderdoktorn AB   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular; Diabetes; Glutaredoxin; Oral glucose tolerance test; Oxidative stress; Redox

Indexed keywords

ANTIGEN; GLUCOSE; GLUTAREDOXIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; BLOOD; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; NONPARAMETRIC TEST; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SPECTROFLUOROMETRY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLUTAREDOXINS; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; SPECTROMETRY, FLUORESCENCE; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84898437474     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0498-2     Document Type: Article

References (24)

1. Padwal RS, Sharma AM (2010) Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can J Cardiol 26(Suppl C):18C-20C
2. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
3. Pitocco D, Zaccardi F, Di Stasio E et al (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud 7:15-25
4. Yang H, Jin X, Kei Lam CW, Yan SK (2011) Oxidative stress and diabetes mellitus. Clin Chem Lab Med 49:1773-1782
5. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-1070
6. Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567-575
7. Hanschmann EM, Godoy JR, Berndt C, Hudemann C, Lillig CH (2013) Thioredoxins, glutaredoxins, and peroxiredoxins-molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal, PMID: 23397885 [Epub ahead of print]
8. Calabrese V, Cornelius C, Leso V et al (2012) Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta 1822:729-736
9. Allen EM, Mieyal JJ (2012) Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal 17:1748-1763
10. Holmgren A (1976) Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc Natl Acad Sci USA 73:2275-2279
11. Lillig CH, Berndt C (2013) Glutaredoxins in thiol/disulfide exchange. Antioxid Redox Signal 18:1654-1665
12. Lundberg M, Fernandes AP, Kumar S, Holmgren A (2004) Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem Biophys Res Commun 319:801-809
13. Miyamoto S, Kawano H, Hokamaki J et al (2005) Increased plasma levels of thioredoxin in patients with glucose intolerance. Intern Med 44:1127-1132
14. Nakamura H, Vaage J, Valen G, Padilla CA, Bjornstedt M, Holmgren A (1998) Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic Biol Med 24:1176-1186
15. Bjornstedt M, Xue J, Huang W, Akesson B, Holmgren A (1994) The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 269:29382-29384
16. Reynaert NL, van der Vliet A, Guala AS et al (2006) Dynamic redox control of NF-kappa B through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103:13086-13091
17. Nakamura H, De Rosa S, Roederer M et al (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603-611
18. Blomback B, Blomback M, Finkbeiner W, Holmgren A, Kowalska-Loth B, Olovson G (1974) Enzymatic reduction of disulfide bonds in fibrin-ogen by the thioredoxin system. I. Identification of reduced bonds and studies on reoxidation process. Thromb Res 4:55-75
19. Ugarte N, Petropoulos I, Friguet B (2010) Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. Antioxid Redox Signal 13:539-549
20. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D (2001) Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 108:635-636
21. Grebenchtchikov N, Sweep CG, Geurts-Moespot A, Piffanelli A, Foekens JA, Benraad TJ (2002) An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood. J Immunol Methods 268:219-231
22. Aesif SW, Kuipers I, van der Velden J et al (2011) Activation of the glutaredoxin-1 gene by nuclear factor kappaB enhances signaling. Free Radic Biol Med 51:1249-1257
23. Ceriello A, Zarich SW, Testa R (2009) Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. J Am Coll Cardiol 53:S9-S13
24. Ivarsson R, Quintens R, Dejonghe S et al (2005) Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54:2132-2142